Showing results (11-20 of 4,456) with videos related to
Sort By:
Pageof 446
Journal of Steroid Biochemistry|August 28, 1990
In vitro inhibition by ketoconazole of human testicular steroid oxidoreductasesY Higashi, K Yoshida, H OshimaEndocrine Journal|February 12, 2000
Effects of intravenous administration of high dose-diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancerS Kitahara, H Umeda, M Yano, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|January 31, 2002
Separation methods applicable to prostate cancer diagnosis and monitoring therapyS Sumi, K Arai, K YoshidaClinica Chimica Acta; International Journal of Clinical Chemistry|May 16, 2000
Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: comparison to voided urine cytology in the detection of transitional cell carcinoma of the bladderS Sumi, K Arai, S Kitahara, et al.Cancer|November 14, 1997
Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinomaK Yoshida, S Sumi, K Arai, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1989
[A study of intercellular communication of human transitional cell carcinoma cell lines]K Kihara, Y Kageyama, S Sumi, et al.Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1990
[A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines]S Sumi, K Kihara, Y Kageyama, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|May 1, 1991
[Macroscopic tumor thrombus in renal cell carcinoma]S Sumi, Y Tachibana, Y Higashi, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|May 13, 1998
[Studies of prostate-specific antigen (PSA) immunoassays--differences in characteristic of immunoreactivity and reference materials among the kits]H Umeda, S Sumi, M Honda, et al.European Urology|January 1, 1997
Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinomaY Hosoya, K Arai, M Honda, et al.Pageof 446